FDA Approvals - Abiomed Receives FDA Approval of The AbioCor(R), the World's First
Abiomed Receives FDA Approval of The AbioCor(R), the World's First Completely Self-Contained, Implantable Artificial (FinanzNachrichten)
Abiomed, ( Nachrichten ) Inc. (NASDAQ: ABMD) announced today it has received Humanitarian Device Exemption (HDE) approval from the U.S. Food and Drug Administration (FDA) for its AbioCor(R) Implantable Replacement Heart (AbioCor).
Applied NeuroSolutions Appoints Healthcare Leader Alan L. Heller to Board of Directors (RedNova)
Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.appliedneurosolutions.com), a biopharmaceutical company developing novel therapeutic targets for the treatment of, and diagnostics for the detection of, Alzheimer's disease (AD), today announced the appointment of Alan L.